These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 31270717)

  • 21. Metastatic melanoma: prognostic factors and survival in patients with brain metastases.
    Frinton E; Tong D; Tan J; Read G; Kumar V; Kennedy S; Lim C; Board RE
    J Neurooncol; 2017 Dec; 135(3):507-512. PubMed ID: 28819707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of radiation, systemic therapy and treatment sequencing on survival of patients with melanoma brain metastases.
    Rauschenberg R; Bruns J; Brütting J; Daubner D; Lohaus F; Zimmer L; Forschner A; Zips D; Hassel JC; Berking C; Kaehler KC; Utikal J; Gutzmer R; Terheyden P; Meiss F; Rafei-Shamsabadi D; Kiecker F; Debus D; Dabrowski E; Arnold A; Garzarolli M; Kuske M; Beissert S; Löck S; Linn J; Troost EGC; Meier F
    Eur J Cancer; 2019 Mar; 110():11-20. PubMed ID: 30739835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neutrophil to lymphocyte ratio is an independent predictor of outcome for patients undergoing definitive resection for stage IV melanoma.
    Kanatsios S; Melanoma Project M; Li Wai Suen CSN; Cebon JS; Gyorki DE
    J Surg Oncol; 2018 Nov; 118(6):915-921. PubMed ID: 30196539
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of Insurance Status With Presentation, Treatment, and Survival in Melanoma in the Era of Immune Checkpoint Inhibitors.
    Jain V; Venigalla S; Reddy VK; Lukens JN; Mitchell TC; Shabason JE
    J Immunother; 2020 Jan; 43(1):8-15. PubMed ID: 31498180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes and patterns of failure of head and neck mucosal melanoma treated with multiple treatment modalities.
    Xu QQ; Lai YZ; Huang ZL; Zeng ZY; Zhang YN; Ou RY; Wu WM; Chen L; Lu LX
    Radiat Oncol; 2021 Jul; 16(1):138. PubMed ID: 34321026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment patterns and outcomes in patients with advanced melanoma in France.
    Bedane C; Leccia MT; Sassolas B; Bregman B; Lebbé C;
    Curr Med Res Opin; 2013 Oct; 29(10):1297-305. PubMed ID: 23808961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sex-Based Differences in Melanoma Survival in a Contemporary Patient Cohort.
    Hieken TJ; Glasgow AE; Enninga EAL; Kottschade LA; Dronca RS; Markovic SN; Block MS; Habermann EB
    J Womens Health (Larchmt); 2020 Sep; 29(9):1160-1167. PubMed ID: 32105561
    [No Abstract]   [Full Text] [Related]  

  • 28. Prolonged survival of patients receiving active immunotherapy with Canvaxin therapeutic polyvalent vaccine after complete resection of melanoma metastatic to regional lymph nodes.
    Morton DL; Hsueh EC; Essner R; Foshag LJ; O'Day SJ; Bilchik A; Gupta RK; Hoon DS; Ravindranath M; Nizze JA; Gammon G; Wanek LA; Wang HJ; Elashoff RM
    Ann Surg; 2002 Oct; 236(4):438-48; discussion 448-9. PubMed ID: 12368672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Survival outcomes of patients with advanced melanoma from 2013 to 2017: Results of a nationwide population-based registry.
    van Zeijl MCT; de Wreede LC; van den Eertwegh AJM; Wouters MWJM; Jochems A; Schouwenburg MG; Aarts MJB; van Akkooi ACJ; van den Berkmortel FWPJ; de Groot JWB; Hospers GAP; Kapiteijn E; Piersma D; van Rijn RS; Suijkerbuijk KPM; Ten Tije AJ; van der Veldt AAM; Vreugdenhil G; van der Hoeven JJM; Haanen JBAG
    Eur J Cancer; 2021 Feb; 144():242-251. PubMed ID: 33373869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment patterns and outcomes among patients diagnosed with unresectable stage III or IV melanoma in Europe: a retrospective, longitudinal survey (MELODY study).
    Lebbe C; Lorigan P; Ascierto P; Testori A; Bédane C; Middleton M; van Baardewijk M; Konto C; Dueymes A; Maio M
    Eur J Cancer; 2012 Nov; 48(17):3205-14. PubMed ID: 22742880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined immunotherapy with nivolumab and ipilimumab with and without local therapy in patients with melanoma brain metastasis: a DeCOG* study in 380 patients.
    Amaral T; Kiecker F; Schaefer S; Stege H; Kaehler K; Terheyden P; Gesierich A; Gutzmer R; Haferkamp S; Uttikal J; Berking C; Rafei-Shamsabadi D; Reinhardt L; Meier F; Karoglan A; Posch C; Gambichler T; Pfoehler C; Thoms K; Tietze J; Debus D; Herbst R; Emmert S; Loquai C; Hassel JC; Meiss F; Tueting T; Heinrich V; Eigentler T; Garbe C; Zimmer L;
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32221017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact on overall survival of the combination of BRAF inhibitors and stereotactic radiosurgery in patients with melanoma brain metastases.
    Wolf A; Zia S; Verma R; Pavlick A; Wilson M; Golfinos JG; Silverman JS; Kondziolka D
    J Neurooncol; 2016 May; 127(3):607-15. PubMed ID: 26852222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival outcomes in an older US population with advanced melanoma and central nervous system metastases: SEER-Medicare analysis.
    Sadetsky N; Hernandez A; Wallick CJ; McKenna EF; Surinach A; Colburn DE
    Cancer Med; 2020 Sep; 9(17):6216-6224. PubMed ID: 32667719
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma.
    Ascierto PA; Del Vecchio M; Mackiewicz A; Robert C; Chiarion-Sileni V; Arance A; Lebbé C; Svane IM; McNeil C; Rutkowski P; Loquai C; Mortier L; Hamid O; Bastholt L; Dreno B; Schadendorf D; Garbe C; Nyakas M; Grob JJ; Thomas L; Liszkay G; Smylie M; Hoeller C; Ferraresi V; Grange F; Gutzmer R; Pikiel J; Hosein F; Simsek B; Maio M
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32503946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased visceral to subcutaneous fat ratio is associated with decreased overall survival in patients with metastatic melanoma receiving anti-angiogenic therapy.
    Grignol VP; Smith AD; Shlapak D; Zhang X; Del Campo SM; Carson WE
    Surg Oncol; 2015 Dec; 24(4):353-8. PubMed ID: 26690825
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A pooled analysis of eastern cooperative oncology group and intergroup trials of adjuvant high-dose interferon for melanoma.
    Kirkwood JM; Manola J; Ibrahim J; Sondak V; Ernstoff MS; Rao U;
    Clin Cancer Res; 2004 Mar; 10(5):1670-7. PubMed ID: 15014018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chronologically changing patterns in the survival of korean patients with breast cancer and related clinical factors: a nationwide registry-based study.
    Lee SB; Ko SS; Park CH; Nam SJ; Choi JE; Jung YS; Park WC; Son BH
    Breast Cancer Res Treat; 2018 Nov; 172(2):273-282. PubMed ID: 30088179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of immunotherapy and surgery for stage IV melanoma.
    Molina G; Kasumova GG; Qadan M; Boland GM
    Cancer; 2020 Jun; 126(11):2614-2624. PubMed ID: 32157676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metastasectomy for melanoma is associated with improved overall survival in responders to targeted molecular or immunotherapy.
    Medina BD; Choi BH; Rodogiannis KG; Moran U; Shapiro RL; Pavlick A; Osman I; Berman RS; Lee AY
    J Surg Oncol; 2020 Sep; 122(3):555-561. PubMed ID: 32441371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characteristics and therapy response in unresectable melanoma patients stage IIIB-IIID with in-transit and satellite metastases.
    Zaremba A; Philip M; Hassel JC; Glutsch V; Fiocco Z; Loquai C; Rafei-Shamsabadi D; Gutzmer R; Utikal J; Haferkamp S; Reinhardt L; Kähler KC; Weishaupt C; Moreira A; Thoms KM; Wilhelm T; Pföhler C; Roesch A; Ugurel S; Zimmer L; Stadtler N; Sucker A; Kiecker F; Heinzerling L; Meier F; Meiss F; Schlaak M; Schilling B; Horn S; Schadendorf D; Livingstone E
    Eur J Cancer; 2021 Jul; 152():139-154. PubMed ID: 34102453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.